Peer-influenced content. Sources you trust. No registration required. This is HCN.
JAMA Network
In this cohort analysis, which included male patients examined at 128 US Veterans Health Administration facilities between 2005 (n = 4,678,412) and 2019 (n = 5,371,701), facilities with greater rates of prostate-specific antigen screening showed lower rates of eventual metastatic prostate cancer incidence.
Oncology, Medical October 31st 2022
The New England Journal of Medicine
In this randomized trial from Poland, Norway, Sweden, and the Netherlands, the study population of approximately 85,000 individuals were randomly assigned to colonoscopy screening or usual care. The risk of colorectal cancer at 10 years was 18% lower in the screening cohort.
Family Medicine/General Practice October 26th 2022
A Narrative Review Liquid biopsy is increasingly being used clinically in advanced lung cancer, according to this review, and ongoing research is identifying applications of circulating tumor DNA-based testing that complement tissue analysis across a wide range of clinical settings. At many stages of the patient’s oncologic journey, circulating tumor DNA technologies are demonstrating potential benefits for patients, health care practitioners, health care systems, and researchers.
Oncology, Medical October 24th 2022
MedPage Today
The study, led by Michael Bretthauer, MD, PhD, of the University of Oslo in Norway, found that people who were invited to have a screening colonoscopy had a lower risk of colorectal cancer than those who were not, though at a lower rate than researchers expected. Furthermore, no significant difference in colorectal cancer-related mortality was discovered between the two groups.
Gastroenterology October 19th 2022
Scientists have started questioning the veracity of images accompanying University of Minnesota Sylvain Lesné, PhD’s studies touting major breakthroughs. Lesné’s images had supported a theory that oligomer species Aβ*56 was the most important of many oligomers thought to be more pathogenic than other plaques — and thus, a potential drug target.
Neurology August 2nd 2022
ReachMD
Offering 0.25 credits, this 30-minute CME program discusses the new cervical cancer screening guidelines recently published by both the American Society for Colonoscopy and Cervical Pathology (ASCCP) and the American Cancer Society (ACS).
Obstetrics & Gynecology July 13th 2022